64 related articles for article (PubMed ID: 1893465)
1. [Treatment of Hodgkin's malignant lymphoma in children and adolescents by immunomodulation with a dialysate of human leukocytes].
Mydlil J
Cesk Pediatr; 1991 May; 46(5):266-9. PubMed ID: 1893465
[TBL] [Abstract][Full Text] [Related]
2. Aspecific transfer factor in children with Hodgkin's disease.
Pasino M; Vadalà CR; Tonini GP; Comelli A; Perutelli P
Boll Ist Sieroter Milan; 1976; 55(2):168-73. PubMed ID: 1088071
[TBL] [Abstract][Full Text] [Related]
3. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
[TBL] [Abstract][Full Text] [Related]
4. Effect of dialysable leukocyte extract on the mononuclear leukocytes in Hodgkin's disease.
Lukács K; Kávai M; Berényi E; Frendl G; Schröder I; Szegedi G
Haematologia (Budap); 1985; 18(2):105-13. PubMed ID: 3161810
[TBL] [Abstract][Full Text] [Related]
5. Increase in E-rosettes after transfer factor (TF) treatment: fractionation of TF.
Khan A; Thometz D; Garrison O; Hill JM
Ann Allergy; 1976 May; 36(5):330-6. PubMed ID: 1084716
[TBL] [Abstract][Full Text] [Related]
6. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
Huang HQ; Cai QC; Shi YX; Lin XB; Wei J; Guo Y; Pan ZH
Ai Zheng; 2006 Aug; 25(8):1023-8. PubMed ID: 16965687
[TBL] [Abstract][Full Text] [Related]
7. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
Matchett KM; Huang AT; Kremer WB
J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
[TBL] [Abstract][Full Text] [Related]
8. [Immunological data in the clinical evaluation of Hodgkin's diseases].
Burchardt K
Z Gesamte Inn Med; 1981 Nov; 36(21):840. PubMed ID: 6977241
[TBL] [Abstract][Full Text] [Related]
9. Characterization and expression of CT45 in Hodgkin's lymphoma.
Heidebrecht HJ; Claviez A; Kruse ML; Pollmann M; Buck F; Harder S; Tiemann M; Dörffel W; Parwaresch R
Clin Cancer Res; 2006 Aug; 12(16):4804-11. PubMed ID: 16914565
[TBL] [Abstract][Full Text] [Related]
10. Production and characterization of a monoclonal antibody that binds Reed-Sternberg cells.
Hecht TT; Longo DL; Cossman J; Bolen JB; Hsu SM; Israel M; Fisher RI
J Immunol; 1985 Jun; 134(6):4231-6. PubMed ID: 3157756
[TBL] [Abstract][Full Text] [Related]
11. Transfer factor therapy for histoplasmosis in a patient with Hodgkin's disease.
Catanzaro A; Spitler LE; Campbell GD; Moser KM
Arch Intern Med; 1981 Mar; 141(4):533-7. PubMed ID: 7212899
[TBL] [Abstract][Full Text] [Related]
12. Implications of persistent T cell abnormalities for the etiology of Hodgkin's disease.
Fisher RI
Cancer Treat Rep; 1982 Apr; 66(4):681-7. PubMed ID: 6210434
[TBL] [Abstract][Full Text] [Related]
13. Subpopulations of human T lymphocytes in patients with Hodgkin's disease before and after treatment.
Karande AA; Gulwani B; Advani SH; Gangal SG
Neoplasma; 1982; 29(2):149-59. PubMed ID: 6981068
[TBL] [Abstract][Full Text] [Related]
14. In vitro stimulation of T-cell rosette formation by antiserum to thymus factor in Hodgkin's disease.
Zółtowska A; Arendt M; Gan J
Arch Immunol Ther Exp (Warsz); 1984; 32(1):51-7. PubMed ID: 6332594
[TBL] [Abstract][Full Text] [Related]
15. Comparative flow immunophenotypic features of the inflammatory infiltrates of Hodgkin lymphoma and lymphoid hyperplasia.
Hudnall SD; Betancourt E; Barnhart E; Patel J
Cytometry B Clin Cytom; 2008 Jan; 74(1):1-8. PubMed ID: 18061945
[TBL] [Abstract][Full Text] [Related]
16. [Case of implantation of human fetal thymus on the immunological reactivity in patients with Hodgkin's disease].
Pekić B; Dujić A; Radojicić B; Radojicić C; Kolasinović N; Martinović N; Susaković N; Radovanović L
Bilt Hematol Transfuz; 1975; 3(1-2):105-19. PubMed ID: 1225309
[TBL] [Abstract][Full Text] [Related]
17. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T
J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte subpopulations and immunoglobulin levels in Hodgkin's disease survivors.
Eckschlager T; Průsa R; Hladíková M; Radvanská J; Slabý K; Radvanský J
Neoplasma; 2004; 51(4):261-4. PubMed ID: 15254656
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 impairs CD4+ T cell activation by inhibition of lck: implications in Hodgkin's lymphoma.
Chemnitz JM; Driesen J; Classen S; Riley JL; Debey S; Beyer M; Popov A; Zander T; Schultze JL
Cancer Res; 2006 Jan; 66(2):1114-22. PubMed ID: 16424048
[TBL] [Abstract][Full Text] [Related]
20. Distinguishing features of the immunology of Hodgkin's disease in children.
Tan CT; De Sousa M; Good RA
Cancer Treat Rep; 1982 Apr; 66(4):969-75. PubMed ID: 7074657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]